The FDA and other regulatory agencies can use TREND data and insights to establish disease burden, determine meaningful outcomes, evaluate underresearched symptoms, and identify real-world patient-based evidence that is critical to evaluating and approving therapies. Read more about how we can help regulatory agencies. »